A case of pseudogout attack after zoledronic acid treatment in primary hyperparathyroidism.

Hypercalcemia hyperparathyroidism pseudogout zoledronic acid.

Journal

Turkish journal of physical medicine and rehabilitation
ISSN: 2587-1250
Titre abrégé: Turk J Phys Med Rehabil
Pays: Turkey
ID NLM: 101719024

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 07 11 2021
accepted: 07 01 2022
medline: 7 6 2022
pubmed: 7 6 2022
entrez: 7 9 2023
Statut: epublish

Résumé

Pseudogout (PG) is an inflammatory arthropathy that develops due to the accumulation of calcium pyrophosphate dihydrate crystals in synovial structures. Herein, we present a 59-year-old male patient with PG developed as a result of zoledronic acid (ZA) infusion, which was administered due to primary hyperparathyroidism. The patient with parathyroid adenoma was given ZA since the calcium level did not decrease despite intravenous saline and loop diuretic. One day after ZA administration, the patient had severe pain, fever, and swelling in joints. The radiograph showed chondrocalcinosis. Calcium pyrophosphate deposition were observed in the arthrocentesis fluid under polarized light. The patient's symptoms regressed after anakinra and colchicine treatment. To the best of our knowledge, this is the first case report of a PG attack after ZA treatment for primary hyperparathyroidism. Additionally, there have been few cases of PG after bisphosphonate treatment for osteoporosis in the literature, signifying that more care should be taken when administering bisphosphonate therapy in patients with risk factors.

Identifiants

pubmed: 37674801
doi: 10.5606/tftrd.2023.10135
pmc: PMC10478547
doi:

Types de publication

Case Reports

Langues

eng

Pagination

377-379

Informations de copyright

Copyright © 2023, Turkish Society of Physical Medicine and Rehabilitation.

Déclaration de conflit d'intérêts

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Références

Joint Bone Spine. 2017 Mar;84(2):213-215
pubmed: 27939801
Ann R Coll Surg Engl. 2018 May;100(5):e106-e108
pubmed: 29607728
Joint Bone Spine. 2013 Mar;80(2):178-82
pubmed: 23022422
Semin Arthritis Rheum. 2021 Feb;51(1):84-94
pubmed: 33360232
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101718
pubmed: 34696986
Cureus. 2021 Jun 13;13(6):e15627
pubmed: 34277244
Curr Rheumatol Rep. 2021 Oct 8;23(10):77
pubmed: 34623546
Mol Biol Rep. 2021 May;48(5):4789-4796
pubmed: 34075537
Medicine (Baltimore). 2017 Mar;96(12):e6177
pubmed: 28328803

Auteurs

Meriç Coşkun (M)

Department of Internal Medicine, Division of Endocrinology and Metabolism, Gazi University Faculty of Medicine, Ankara, Türkiye.

Emre Demir (E)

Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Türkiye.

Abdurrahman Tufan (A)

Department of Internal Medicine, Division of Rheumatology, Gazi University Faculty of Medicine, Ankara, Türkiye.

Afruz Babayeva (A)

Department of Internal Medicine, Division of Endocrinology and Metabolism, Gazi University Faculty of Medicine, Ankara, Türkiye.

Mehmet Muhittin Yalçın (MM)

Department of Internal Medicine, Division of Endocrinology and Metabolism, Gazi University Faculty of Medicine, Ankara, Türkiye.

Alev Altınova (A)

Department of Internal Medicine, Division of Endocrinology and Metabolism, Gazi University Faculty of Medicine, Ankara, Türkiye.

Müjde Aktürk (M)

Department of Internal Medicine, Division of Endocrinology and Metabolism, Gazi University Faculty of Medicine, Ankara, Türkiye.

İlhan Yetkin (İ)

Department of Internal Medicine, Division of Endocrinology and Metabolism, Gazi University Faculty of Medicine, Ankara, Türkiye.

Classifications MeSH